Skip to main content
. 2020 Jan 31;21(3):957. doi: 10.3390/ijms21030957

Figure 3.

Figure 3

In vivo antitumor activity of cyclophosphamide in mice (C57BL mice) bearing LLC xenograft model. (A) Tumor volume of the mice in each group during the observation period. (B) After being administered with cyclophosphamide at a dose of 25 mg/kg every other day for 21 days, the mice were sacrificed and the tumors weighed. (C) H&E staining of tumor tissue from saline and Met-2 group. ***p < 0.001.